SCORSETTI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 11.930
EU - Europa 2.493
AS - Asia 460
AF - Africa 365
SA - Sud America 24
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 17
Totale 15.312
Nazione #
US - Stati Uniti d'America 11.847
IE - Irlanda 638
FI - Finlandia 621
NG - Nigeria 360
CN - Cina 282
DE - Germania 277
FR - Francia 226
IT - Italia 170
NL - Olanda 139
SE - Svezia 138
GB - Regno Unito 104
CA - Canada 77
BE - Belgio 65
TR - Turchia 47
IL - Israele 41
IN - India 39
CZ - Repubblica Ceca 32
AU - Australia 20
RU - Federazione Russa 18
HK - Hong Kong 15
A2 - ???statistics.table.value.countryCode.A2??? 13
AT - Austria 13
CL - Cile 13
SG - Singapore 13
GR - Grecia 8
NO - Norvegia 8
RO - Romania 8
BR - Brasile 7
ES - Italia 7
PL - Polonia 7
UA - Ucraina 6
IR - Iran 5
EU - Europa 4
JP - Giappone 4
PA - Panama 4
BD - Bangladesh 3
ID - Indonesia 3
NZ - Nuova Zelanda 3
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
IQ - Iraq 2
MX - Messico 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
ZA - Sudafrica 2
CH - Svizzera 1
KE - Kenya 1
KR - Corea 1
MD - Moldavia 1
PT - Portogallo 1
SI - Slovenia 1
VN - Vietnam 1
Totale 15.312
Città #
Wilmington 2.602
Chandler 2.153
San Mateo 1.014
Ann Arbor 720
Dublin 635
Helsinki 621
Leawood 456
Lawrence 435
Princeton 435
Benin City 360
Boardman 346
Fairfield 261
Shanghai 256
Woodbridge 251
Paris 225
New York 218
Ashburn 203
Amsterdam 134
Milan 83
London 79
Norwalk 71
Seattle 68
Brussels 64
Toronto 62
San Diego 52
Kocaeli 46
Hanover 45
Phoenix 36
Brno 28
Falkenstein 23
Redwood City 23
Monmouth Junction 19
Des Moines 18
Redmond 17
Pune 14
Vienna 11
Beijing 9
Andover 8
Abbiategrasso 7
Clearwater 7
Berlin 6
Cambridge 6
Collegeville 6
Frankfurt am Main 6
Moscow 6
Las Vegas 5
Santa Clara 5
Cupertino 4
Houston 4
Kemerovo 4
Prague 4
Singapore 4
St Petersburg 4
São Paulo 4
Tappahannock 4
Taranto 4
Apo 3
Athens 3
Central District 3
Chandigarh 3
Eden Prairie 3
Jacksonville 3
Jakarta 3
La Canada Flintridge 3
Ottawa 3
Tokyo 3
Vaddangi 3
Augusta 2
Bagnara di Romagna 2
Belleville 2
Bogotá 2
Budapest 2
Buffalo 2
Chennai 2
Falls Church 2
Farmington 2
Guangzhou 2
Hamilton 2
Henderson 2
Lima 2
Livorno 2
Los Angeles 2
Manchester 2
Melbourne 2
Meppel 2
Montreal 2
Mumbai 2
Niagara Falls 2
Perth 2
Poznan 2
Raleigh 2
Rimini 2
Shimla 2
Taipei 2
Thrissur 2
Tilburg 2
Treviso 2
Vancouver 2
Visakhapatnam 2
Warsaw 2
Totale 12.290
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 94
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 83
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 74
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 71
Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients A 18-Year Experience at a Single High-volume Referral Center 68
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 66
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 65
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 62
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 60
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 58
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 57
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 56
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 56
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 55
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 54
Hypofractionated stereotactic radiation therapy in skull base meningiomas 54
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 54
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 54
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 53
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 53
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 53
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 53
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 53
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 52
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 52
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 52
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 52
Stereotactic radiotherapy with linear accelerators. Dosage considerations on collimators and photon beam energy 51
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 51
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 51
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 51
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 50
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 50
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 50
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 50
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 50
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 49
Organs at risk in lung SBRT 49
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 49
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 49
Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy 49
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 49
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 49
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 49
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 48
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series. 48
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 48
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. 47
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 47
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 47
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 47
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 47
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 47
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 47
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 47
Long term follow up of Metastatic Epidural Spinal Cord Compression (MESCC) patients from breast cancer treated with surgery followed by radiotherapy. 47
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 46
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 46
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 46
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 46
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 46
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 46
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 46
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 45
Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study 45
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 45
MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO) 44
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. 44
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 44
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 44
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 44
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 44
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 44
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 44
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in a observational study 44
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case. 44
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 44
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 44
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 43
Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials. 43
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 43
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 43
Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer. 43
Results of a feed-back learning process for RapidPlan knowledge based planning 43
Advantages of a system of positioning and localization made of thermo-conformable materials for irradiation of cervicofacial and encephalic lesions treated with stereotactic fractionated radiation 43
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 43
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 43
Electrolyte abnormalities and side effects of zoledronate in patients with bone metastases 43
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 43
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 43
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 43
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective 43
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 42
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 42
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 42
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 42
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 42
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 42
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 42
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 42
Totale 4.950
Categoria #
all - tutte 111.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202056 0 0 0 0 0 0 0 0 0 0 0 56
2020/20214.698 40 51 63 45 17 1.475 604 382 992 521 15 493
2021/20222.192 98 21 31 545 13 10 87 367 195 235 511 79
2022/20236.227 940 180 540 709 548 512 20 521 1.171 535 482 69
2023/20242.383 207 383 817 118 156 303 128 140 131 0 0 0
Totale 15.556